Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein: Rapid reversion during replication

Virus Research

Volumn 41, Issue 1, 1996, Pages 25-42

  Granowitz, Craig ^a   Berkowitz, Robert D ^a   Goff, Stephen P ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

Cytoplasmic domain; Envelope protein; Moloney murine leukemia virus; Virus replication

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASMIC DOMAIN; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS MUTANT; VIRUS REPLICATION;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE;

EID: 0029967817     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(95)01278-8     Document Type: Article

References (52)

1. Battini, J., Heard, J.M. and Danos, O. (1992) Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J. Virol. 66, 1468-1475.
2. Cheseboro, B. and Wehrly, K. (1985) Different murine cell lines manifest unique patterns of interference to superinfection by murine leukemia viruses. Virology 141, 119-129.
3. Colicelli, J. and Goff, S.P. (1987) Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57, 37-45.
4. Colicelli, J. and Goff, S.P. (1988) Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 199, 47-59.
5. Crawford, S. and Goff, S.P. (1985) A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J. Virol. 53, 899-907.
6. Delwart, E.L. and Panganiban, A.T. (1989) Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J. Virol. 63, 273-280.
7. Dickson, C., Eisenman, R., Fan, H., Hunter, E. and Teich, N. (1984) Protein biosynthesis and assembly. In: R. Weiss, N. Teich, H. Varmus and J. Coffin, (Eds.), RNA Tumor Viruses. Cold Spring Harbor Press, Cold Spring Harbor, New York, pp. 513-648.
8. Doyle, C., Sambrook, J. and Gething, M. (1986) Analysis of progressive deletions of the transmembrane and cytoplasmic domains of influenza hemagglutinin. J. Cell. Biol. 103, 1193-1204.
9. Durbin, R.K. and Manning, J.S. (1984) Coordination of cleavage of gag and env gene products of murine leukemia virus: implications regarding the mechanism of processing. Virology 134, 368-374.
10. Facke, M., Janetzko, A., Shoeman, R.L. and Krausslich, H.-G. (1993) A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 67, 4972-4980.
11. Famulari, N.G., Buchhagen, D.L., Klenk, H.-D. and Fleissner, R. (1976) Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J. Virol. 20, 501-508.
12. Felkner, R.H. and Roth, M.J. (1992) Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J. Virol. 66, 4258-4264.
13. Freed, E.O. and Risser, R. (1987) The role of envelope glycoprotein processing in murine leukemia virus infection. J. Virol. 61, 2852-2856.
14. Gebhardt, A., Bosch, J.V., Ziemiecki, A. and Friis, R.R. (1984) Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. J. Mol. Biol. 174, 297-317.
15. Goff, S.P., Traktman, P. and Baltimore, D. (1981) Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38, 239-248.
16. Granowitz, C., Colicelli, J. and Goff, S.P. (1991) Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance. Virology 183, 545-554.
17. Green, N., Shinnick, T.M., Witte, O., Ponticelli, A., Sutcliffe, J. G. and Lerner, R.A. (1981) Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. U.S.A. 78, 6023-6027.
18. Hartman, S.C. and Mulligan, R.C. (1988) Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 85, 8047-8051.
19. Heard, J.M. and Danos, O. (1991) An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65, 4026-4032.
20. Henderson, L.E., Sowder, R., Copeland, T.D., Smythers, G. and Oroszlan, S. (1984) Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 52, 492-500.
21. Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-371.
22. Hunter, E. and Swanstrom, R. (1990) Retrovirus envelope glycoproteins. Curr. Topics Microbiol. and Immunol. 157, 187-253.
23. Karshin, W.L., Arcement, L.J., Naso, R.B. and Arlinghaus, R.B. (1977) Common precursor for Rauscher leukemia virus gp69/71, p15(E) and p12(E). J. Virol. 23, 787-798.
24. Katoh, I., Yoshinaka, Y., Rein, A., Shibuya, M., Odaka, T. and Oroszlan, S. (1985) Murine leukemia virus maturation: protease region required for conversion from 'immature' to 'mature' core form and for virus infectivity. Virology 145, 280-292.
25. Katz, R.A., Kotler, M. and Skalka, A.M. (1988) Cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implications for mechanisms of control. J. Virol. 62, 2686-2695.
26. Kennel, S.J., Del Villano, B.C., Levy, R.L. and Lerner, R.A. (1973) Properties of an oncovirus glycoprotein: Evidence for its presence on the surface of virions and infected cells. Virology 55, 464-475.
27. Markowitz, D., Goff, S. and Bank, A. (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
28. Martinelli, S.C. and Goff, S.P. (1990) Rapid reversion of a deletion mutation in Moloney murine leukemia virus by recombination with a closely related endogenous provirus. Virology 174, 135-144.
29. McCutchan, J.H. and Pagano, J.S. (1968) Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J. Natl. Cancer Inst. 41, 351-357.
30. Ng, V.L., Wood, T.G. and Arlinghaus, R.B. (1982) Processing of the env gene products of Moloney murine leukemia virus. J. Gen. Virol. 59, 329-343.
31. Odawara, T., Yoshikura, H., Ohshima, M., Tanaka, T., Jones, D.S., Nemoto, F., Kuchino, Y. and Iwamoto, A. (1991) Analysis of Moloney murine leukemia virus revertants mutated at the gag-pol junction. J. Virol. 65, 6376-6379.
32. Perez, L.G., Davis, G.L. and Hunter, E. (1987) Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and/or cytoplasmic domains: analysis of intracellular transport and assembly into virions. J. Virol. 61, 2981-2988.
33. Pettit, S.C., Simsic, J., Loeb, D.D., Everitt, L., Hutchison, C.A.D. and Swanstrom, R. (1991) Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 266, 14539-14547.
34. Pinter, A. and Fleissner, E. (1979) Structural studies of retroviruses: characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J. Virol. 30, 157-165.
35. Pinter, A., Honnen, W.J., Tung, J.-S., O'Donnell, P.V. and Hammerling, U. (1982) Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116, 499-516.
36. Polonoff, E., Machida, C.A. and Kabat, D. (1982) Glycosylation and intracellular transport of membrane glycoproteins encoded by murine leukemia viruses. J. Biol. Chem. 257, 14023-14028.
37. Ragheb, J.A. and Anderson, W.F. (1994a) Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J. Virol. 68, 3207-3219.
38. Ragheb, J.A. and Anderson, W.F. (1994b). pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R-peptide and p12E TM in viral entry. J. Virol. 68, 3220-3231.
39. Rein, A. (1982) Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses on mouse cells. Virology 120, 251-257.
40. Rein, A., Mirro, J., Haynes, J.G., Ernst, S.M. and Nagashima, K. (1994) Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein. J. Virol. 68, 1773-1781.
41. Rein, A. and Schultz, A. (1984) Different recombinant murine leukemia viruses use different cell surface receptors. Virology 136, 144-152.
42. Rein, A., Schultz, A.M., Bader, J.P. and Bassin, R.H. (1982) Inhibitors of glycosylation reverse retroviral interference. Virology 119, 185-192.
43. Robinson, H.L., Astrin, S.M., Senior, A.M. and Salazar, F.H. (1981) Host susceptibility to endogenous viruses: defective glycoprotein-expressing proviruses interfere with infections. J. Virol. 40, 745-751.
44. Rowe, W.P., Pugh, W.E. and Hartley, J.W. (1970) Plaque assay techniques for murine leukemia viruses. Virology 42, 1136-1139.
45. Schultz, A.M. and Oroszlan, S. (1979) Tunicamycin inhibits glycosylation of precursor polyprotein encoded by Env gene of Rauscher murine leukemia virus. Biochem. Biophys. Res. Commun. 86, 1206-1213.
46. Schwartzberg, P., Colicelli, J. and Goff, S.P. (1985) Recombination between a defective retrovirus and homologous sequences in host DNA: reversion by patch repair. J. Virol. 53, 719-726.
47. Southern, P.J. and Berg, P. (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-341.
48. Tanese, N., Roth, M.J. and Goff, S.P. (1986) Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J. Virol. 59, 328-340.
49. van Zaane, D., Dekker-Michielsen, M.J.A. and Bloemers, H.P.J. (1976) Virus-specific precursor polypeptides in cells infected with Rauscher leukemia virus: synthesis, identification, and processing. Virology 75, 113-129.
50. Wigler, M., Sweet, R., Sim, G.K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S. and Axel, R. (1979) Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16, 777-785.
51. Witte, O.N., Tsukamoto-Adey, A. and Weissman, I.L. (1977) Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes. Virology 76, 539-553.
52. Yu, X.F., Yuan, X., Matsuda, Z., Lee, T.H. and Essex, M. (1992) The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66, 4966-4971.